These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 27354590)

  • 21. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
    Wu H; Xiao Z; Wang K; Liu W; Hao Q
    Biochem Biophys Res Commun; 2013 Nov; 441(4):693-700. PubMed ID: 24157791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b.
    Luo S; Wang J; Ma Y; Yao Z; Pan H
    Biochem Biophys Res Commun; 2015 Jun; 462(2):85-90. PubMed ID: 25944662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.
    Tang H; Yao L; Tao X; Yu Y; Chen M; Zhang R; Xu C
    Int J Mol Med; 2013 Aug; 32(2):381-8. PubMed ID: 23722670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling.
    Chen P; Zeng M; Zhao Y; Fang X
    Oncol Rep; 2014 Nov; 32(5):2070-6. PubMed ID: 25190487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression.
    Ying X; Li-ya Q; Feng Z; Yin W; Ji-hong L
    Biomed Pharmacother; 2015 Apr; 71():64-9. PubMed ID: 25960217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer.
    Li J; Liang S; Yu H; Zhang J; Ma D; Lu X
    Gynecol Oncol; 2010 Dec; 119(3):543-8. PubMed ID: 20869762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
    Wu Q; Guo R; Lin M; Zhou B; Wang Y
    Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
    Yang C; Cai J; Wang Q; Tang H; Cao J; Wu L; Wang Z
    Gynecol Oncol; 2012 Feb; 124(2):325-34. PubMed ID: 22005523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
    Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
    Li J; Liang SH; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma.
    Kinoshita T; Nohata N; Yoshino H; Hanazawa T; Kikkawa N; Fujimura L; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Oncol; 2012 Jan; 40(1):185-93. PubMed ID: 21922130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells.
    Wang L; Mezencev R; Švajdler M; Benigno BB; McDonald JF
    Gynecol Oncol; 2014 Jul; 134(1):96-103. PubMed ID: 24802724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
    Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
    Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
    Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
    Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer.
    Wang XW; Xi XQ; Wu J; Wan YY; Hui HX; Cao XF
    Oncol Rep; 2015 Mar; 33(3):1402-10. PubMed ID: 25607234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.
    Zhang H; Zuo Z; Lu X; Wang L; Wang H; Zhu Z
    Oncol Rep; 2012 Feb; 27(2):594-8. PubMed ID: 22076535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
    Xia Y; Gao Y
    Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
    Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H
    J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functionality of the Tumor Suppressor
    Stope MB; Cernat V; Kaul A; Diesing K; Koensgen D; Burchardt M; Mustea A
    Anticancer Res; 2018 Mar; 38(3):1547-1550. PubMed ID: 29491084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.